MODERN APPROACHES TO DRUG TREATMENT OF OBESITY

Шагазатова Б.Х., Кудратова Н.А.

Марказий Осиё эндокринологик журнали · 2023-yil

Annotatsiya

Obesity is a chronic and relapsing disease that not only disrupts metabolism, but is also a risk factor for cardiovascular disease. Although behavioral therapy is important in treating obesity, it is difficult to reach the ideal weight and maintain long-term weight loss on its own. Therefore, obesity guidelines strongly recommend initiation of medication therapy in patients with BMI ≥30 kg/m 2 and BMI ≥27 kg/m 2 with concomitant weight-related diseases, such as DM2. There is ample evidence to support that pharmacotherapy combined with behavioral interventions can lead to significant weight loss and improved cardiometabolism. One strategy for long-term control of obesity is that weight loss medications should be individualized for each patient, depending on their comorbidities and preferences.

Maqola ma’lumotlari
MualliflarШагазатова Б.Х., Кудратова Н.А.
JurnalМарказий Осиё эндокринологик журнали
Nashr sanasi2023-05-13
Jild3
Son1
TilRus

Kalit so‘zlar

ожирение, медикаментозное лечение ожирения, лираглутид, семаглутид, орлистат, сибутрамин, obesity, drug treatment of obesity, liraglutide, semaglutide, orlistat, sibutramine

Ilmiy soha

Марказий Осиё эндокринологик журнали jurnalidan boshqa maqolalar

Марказий Осиё эндокринологик журнали — barcha maqolalar